Reliance Pharma Fund (G)
Summary Info
Fund Name : Reliance Mutual Fund
Scheme Name : Reliance Pharma Fund (G)
AMC : Reliance Mutual Fund
Type : Open
Category : Equity - Pharma
Launch Date : 10-May-04
Fund Manager : Sailesh Raj Bhan
Net Assets (Rs. cr) : 1235.15
NAV Details
NAV Date : 23-Jun-17
NAV [Rs.] : 127.05
Buy/Resale Price [Rs.] : 125.78
Sell/Repurchase Price [Rs.] : 127.05
Entry Load % : Nil
Exit Load % : Nil
NAV Chart
Performance(%)
* returns above 1 yr. are annualized
  1w 1m 3m 6m 1y 3y 5y Since INC
Scheme Returns [0.24] 3.25 [6.53] [4.50] [2] 11.15 17.25 21.49
Category Avg [0.45] 1.53 [7.01] [2.37] [3.90] 11.57 17.57 11.10
Category Best [0.22] 3.33 [4.25] 1.90 [1.17] 14.22 20.39 21.49
Category Worst [0.89] [1.17] [10.36] [4.50] [6.77] 9.27 15.38 [9.53]
Latest Payouts
  Dividends Bonus
Ratio NA NA
Date NA NA
Investment Details
Min. Investment(Rs.) : 5000
Increm.Investment(Rs.) : 1
In & Out
In
Name of the Company No of shares
No Data Found
Out
Name of the Company No of shares
Apollo Hospitals 175000
Narayana Hrudaya 259183
Fund Holdings
Asset Type Instrument Name Industry Net Assets(%) No of Shares Mkt Value(Cr.)
Equity & Equity related Investments
Equity Aurobindo Pharma Pharmaceuticals 9.53 2,050,000.00 117.70
Equity Divi's Lab. Pharmaceuticals 9.43 2,000,014.00 116.43
Equity Dr Reddy's Labs Pharmaceuticals 9.21 450,871.00 113.79
Equity Abbott India Pharmaceuticals 9.14 270,255.00 112.91
Equity Cadila Health. Pharmaceuticals 8.64 2,300,000.00 106.74
Equity Sanofi India Pharmaceuticals 8.37 253,207.00 103.43
Equity Lupin Pharmaceuticals 8.27 880,025.00 102.17
Equity Sun Pharma.Inds. Pharmaceuticals 7.31 1,800,350.00 90.31
Equity Cipla Pharmaceuticals 6.27 1,500,903.00 77.50
Equity Thyrocare Tech. Healthcare Services 5.73 988,589.00 70.75
Equity Max India Healthcare Services 4.82 4,009,533.00 59.52
Equity Health.Global Healthcare Services 4.05 2,026,255.00 50.04
Equity Glenmark Pharma. Pharmaceuticals 3.28 637,200.00 40.57
Equity Ipca Labs. Pharmaceuticals 2.78 700,000.00 34.35
Equity Torrent Pharma. Pharmaceuticals 2.15 215,000.00 26.51
 
Derivative Investments
Derivatives Derivatives -/- 0.24 0.00 3
 
Cash & Cash Equivalent
CBLO CBLO -/- 2.20 0.00 27.19
Cash & Cash Equivalent C C I -/- 0 0.00 0.01
Net CA & Others Net CA & Others -/- [1.42] 0.00 [17.77]
 
 
Fund Manager Speak

Nagarajan Murthy, Head of Fixed Income, Tata Asset Management

“We expect the ten‐year Government securities yields to move in the range of 6.70‐ 7.10 % in the next financial year. We expect AAA PS...

 
My wealth at retirement

Calculate the worth of your wealth at retirement

My age (years)
Age I plan to retire (years)
Current savings (Rs.)
Monthly savings (Rs.)
ROI(% p.a.)
Key Information
Fund House : Reliance Mutual Fund
Incorporation Date : 24-Feb-1995
Total Assets Managed (Cr.) : 211,738.30
Trustee/s : Reliance Capital Trustee
Chairman : N/A
CEO / MD : Mr. Sundeep Sikka
CIO : N/A
President : N/A
Director/s : Mr. Sushil C. Tripathi
Compliance Officer/s : Mr. Muneesh Sud
Investor Service Officer/s : Mr. Bhalchandra Joshi
Fund Manager/s : Sailesh Raj Bhan
Other Information
Auditors : N/A
Registered Office : One Indiabulls Centre, Tower 1, 12th Flr, 841, Senapati Bapat Marg, Elphinstone Road, Mumbai-400013
Contact Nos : 022-30994600
Fax : 022-30994699
Email : customer_care@reliancemutual.com
Website : www.reliancemutual.com
welcome to iifl